A user experience evaluation of a Huntington’s disease app: Implications for mobile-first design
Objective: To evaluate usability, functionality, and interface design to inform improvements for future iterations of the GEORGE® app for use in research. Background: GEORGE® is…Late-onset cerebellar ataxia: case report of a new CNV on TTBK2 gene as possible cause of SCA-11
Objective: To describe a case of spinocerebellar ataxia type 11 caused by the copy number variant 43008859_43075833 on the TKKB2 gene Background: The spinocerebellar ataxias…Robust methods for missing covariates in longitudinal studies with application to biomarker research in Parkinson’s disease dementia
Objective: We propose a nonparametric method for handling different types of missing covariates in longitudinal studies. We show that the proposed method outperforms multiple standard…A Report from Japan on Initial Experiences with Adaptive Deep Brain Stimulation Therapy for Patients with Advanced Parkinson’s Disease
Objective: Here we present our initial experience with deep brain stimulation therapy (DBS) for Parkinson's disease (PD) using the closed-loop system. Background: Although DBS is…Microglial activation facilitates alpha synuclein propagation and neurodegeneration in αSyn preformed fibrils (PFF)-injected PD mouse model
Objective: To evaluate whether microglial activation aggravates synucleinopathy progression in Parkinson's disease (PD) mouse model. Background: Alpha-synuclein (αSyn) accumulation underlay the main pathological process of…Co-contractions as a Biomarker for DBS Efficacy in Dystonia
Objective: Deep brain stimulation of the globus pallidus interna (GPi-DBS) is a treatment option for medication-refractory dystonia. However, the clinical outcome after DBS-GPi is variable,…Novel strategies based on sensory electrical stimulation to manage tremor in Parkinson’s disease. A pilot study.
Objective: Tremor can be a disabling motor symptom in patients with Parkinson´s disease (PD) and in some patients is refractory to medication. Here we present…Progress of the UK Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial
Objective: This abstract provides an overview of the progress of the CHIEF-PD trial. Background: Falls are a common and debilitating consequence of Parkinson’s disease (PD).…The potential role of Per- and Polyfluoroalkyl Substances (PFAS) in movement disorders: Implications and Risk assessment to Human Health
Objective: The objective of our study is to critically summarized the neurotoxicity of Perfluoroalkyl substances (PFAS) and linked this environmental pollutant with movement disorders and…Whole exome sequencing in 62 families with early-onset movement disorders, cerebellar ataxia and hereditary spastic paraplegia from Kazakhstan, Tajikistan, and Azerbaijan
Objective: To report the results of whole-exome sequencing (WES) in 62 families with early-onset movement disorders, cerebellar ataxia, and hereditary spastic paraplegia (HSP) from Kazakhstan,…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 153
- Next Page »